Baxter International | BAX - تكلفة المبيعات

سعر السهم
17.22
التغيير اليومي
-0.08 -0.46%
شهريا
-4.60%
سنويا
-38.15%
Q2 التوقعات
16.18




تكلفة المبيعات تغيير تاريخ
Abbott USD 4.92B 535M 2025-12
AngioDynamics USD 37.29M 786K 2025-09
Artivion USD 42.85M 3.86M 2025-12
AtriCure USD 35.16M 2.23M 2025-12
Avanos Medical USD 94.9M 3.1M 2025-12
Baxter International USD 2.4B 512M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Boston Scientific USD 1.84B 82M 2025-12
Cooper Companies USD 376.8M 87.4M 2025-12
Dexcom USD 466.9M 11M 2025-12
Edwards Lifesciences USD 343M 2.2M 2025-12
Fresenius EUR 4.45B 262M 2025-12
Globus Medical USD 290.47M 8.09M 2025-12
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
ICU Medical USD 337.72M 1.61M 2025-12
Inogen USD 39.59M 1.27M 2024-09
Insulet USD 215.2M 19M 2025-12
Integra LifeSciences USD 193.44M 1.62M 2025-12
Intuitive Surgical USD 961.9M 119.2M 2025-12
J&J USD 7.97B 689M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Masimo USD 165.2M 24.3M 2025-12
Medtronic USD 3.61B 83M 2025-12
Merit Medical Systems USD 198.58M 838K 2025-12
Quest Diagnostics USD 1.93B 27M 2025-12
Smith & Nephew USD 870M 17M 2025-12
Stryker USD 2.69B 373M 2025-12
Tandem Diabetes Care USD 122.92M 7.96M 2025-12
Teleflex USD 261.54M 199.84M 2025-12
Terumo JPY 143.44B 15.47B 2025-12
Zimmer Biomet Holdings USD 970.1M 234.3M 2025-12